.png&w=128&q=75&dpl=dpl_12GFXQLWUGiKNLoucfwRHTpxNjaN)
Sapiens Shield
Global project to stop chronic disease worldwide with CellSonic technology.
About Sapiens Shield
PURPOSE
The purpose of Sapiens Shield is to demonstrate that chronic diseases can be stopped safely without side effects using CellSonic VIPP.
METHOD
This is biophysics, not biochemistry. The narrator is Professor Andrew Hague. The pictures were arranged by Dr Glen Halls.
Professor Jorge Curé explaining cell voltage
Professor Jorge Curé — Cell Voltage
The electrical properties of cells has been known for decades. See Professor Jorge Curé explaining cell voltage. Keep in mind that Professor Curé refers to Professor Bjorn Nordenström of the Karolinska Institute in Stockholm.
Professor Bjorn Nordenström — Electroporation
Professor Nordenström discovered electroporation. See what was discovered many years ago. Professor Hague has done better and developed non-surgical, irreversible electroporation. Nothing is stuck into the body. There are no side effects and pain is stopped. This is what Sapiens Shield will use.
Professor Bjorn Nordenström
The World's Next Great Company
Sapiens Shield represents a transformative investment opportunity in healthcare innovation. CellSonic Ltd is inviting strategic investors to join in building what could become one of the world's most impactful healthcare companies.
Global Market
Healthcare is a $12 trillion global market. CellSonic operates across 60+ countries with a proven technology platform that addresses chronic disease — the fastest-growing healthcare challenge worldwide.
Proven Technology
CellSonic VIPP technology has 40+ years of development, thousands of successful treatments, and a growing body of clinical evidence. This is not speculative — it is proven and deployed.
Exponential Growth
With rising chronic disease rates, antibiotic resistance, and demand for non-invasive treatments, CellSonic is positioned at the intersection of multiple healthcare megatrends.
Multi-Market Platform
From medical to veterinary to beauty — CellSonic technology spans multiple billion-dollar markets with distinct product lines and revenue streams.
Capital-Efficient
Low manufacturing costs, high treatment margins, and a franchise model that accelerates global deployment with minimal capital requirements.
IP Protection
Proprietary VIPP technology, extensive clinical documentation, and a global network of trained practitioners create significant competitive barriers.
Request Investment Portfolio Presentation
Interested in learning more about this investment opportunity? Contact our team to receive a comprehensive investment portfolio presentation with detailed financials, growth projections, and partnership structures.
Biophysics properties
Biophysics Properties
Watch the full presentation on the biophysics properties that underpin CellSonic VIPP technology and the Sapiens Shield project.
DIAGNOSE AND CURE
Many people have chronic disease. It does not cure because their immune system has failed. As is now known, this needs biophysics, not biochemistry, and Sapiens Shield has access to the ultimate in biophysics.
Wound Healing
See the video for further information about healing non-healing wounds.
Watch on YouTubeHealing non-healing wounds
.png&w=256&q=75&dpl=dpl_12GFXQLWUGiKNLoucfwRHTpxNjaN)